These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12629200)

  • 1. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.
    Marchi N; Fazio V; Cucullo L; Kight K; Masaryk T; Barnett G; Vogelbaum M; Kinter M; Rasmussen P; Mayberg MR; Janigro D
    J Neurosci; 2003 Mar; 23(5):1949-55. PubMed ID: 12629200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum S-100beta as a possible marker of blood-brain barrier disruption.
    Kapural M; Krizanac-Bengez Lj; Barnett G; Perl J; Masaryk T; Apollo D; Rasmussen P; Mayberg MR; Janigro D
    Brain Res; 2002 Jun; 940(1-2):102-4. PubMed ID: 12020881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizure-promoting effect of blood-brain barrier disruption.
    Marchi N; Angelov L; Masaryk T; Fazio V; Granata T; Hernandez N; Hallene K; Diglaw T; Franic L; Najm I; Janigro D
    Epilepsia; 2007 Apr; 48(4):732-42. PubMed ID: 17319915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral markers of brain damage and blood-brain barrier dysfunction.
    Marchi N; Rasmussen P; Kapural M; Fazio V; Kight K; Mayberg MR; Kanner A; Ayumar B; Albensi B; Cavaglia M; Janigro D
    Restor Neurol Neurosci; 2003; 21(3-4):109-21. PubMed ID: 14530574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
    J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ; Farhavar A; Gee C; Hawthorn B; He H; Nayak A; Stöcklein V; Bazarian JJ
    J Neurotrauma; 2009 Sep; 26(9):1497-1507. PubMed ID: 19257803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.
    Kanner AA; Marchi N; Fazio V; Mayberg MR; Koltz MT; Siomin V; Stevens GH; Masaryk T; Aumayr B; Vogelbaum MA; Barnett GH; Janigro D
    Cancer; 2003 Jun; 97(11):2806-13. PubMed ID: 12767094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
    Marchi N; Mazzone P; Fazio V; Mekhail T; Masaryk T; Janigro D
    Cancer; 2008 Mar; 112(6):1313-24. PubMed ID: 18257091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier damage induces release of alpha2-macroglobulin.
    Cucullo L; Marchi N; Marroni M; Fazio V; Namura S; Janigro D
    Mol Cell Proteomics; 2003 Apr; 2(4):234-41. PubMed ID: 12714567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood-brain barrier opening microcirculation in human brain tumor].
    Sato S; Toya S; Otani M
    No To Shinkei; 1985 Feb; 37(2):109-13. PubMed ID: 2988587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation.
    Terazaki H; Ando Y; Nakamura M; Obayashi K; Misumi S; Shoji S; Yamashita S; Nakagawa K; Ishizaki T; Suhr O; Uemoto S; Inomata Y; Tanaka K
    Transplantation; 2001 Jul; 72(2):296-9. PubMed ID: 11477356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain.
    Chanoine JP; Alex S; Fang SL; Stone S; Leonard JL; Körhle J; Braverman LE
    Endocrinology; 1992 Feb; 130(2):933-8. PubMed ID: 1733735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is peripheral immunity regulated by blood-brain barrier permeability changes?
    Bargerstock E; Puvenna V; Iffland P; Falcone T; Hossain M; Vetter S; Man S; Dickstein L; Marchi N; Ghosh C; Carvalho-Tavares J; Janigro D
    PLoS One; 2014; 9(7):e101477. PubMed ID: 24988410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of brain-derived proteins in cerebrospinal fluid.
    Reiber H
    Clin Chim Acta; 2001 Aug; 310(2):173-86. PubMed ID: 11498083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma.
    Hill SA; Neuwelt EA
    J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.
    Castaño EM; Roher AE; Esh CL; Kokjohn TA; Beach T
    Neurol Res; 2006 Mar; 28(2):155-63. PubMed ID: 16551433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
    Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
    Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
    Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
    Pleines UE; Morganti-Kossmann MC; Rancan M; Joller H; Trentz O; Kossmann T
    J Neurotrauma; 2001 May; 18(5):491-8. PubMed ID: 11393252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.